What Comes after NCI-MATCH? NCI’s New Precision Medicine Cancer Trials

SubscribeDecember 6, 2023, by James H. Doroshow, M.D.Findings from NCI-MATCH and its successor trials will help oncologists implement precision medicine in everyday patient care.Credit: iStockMore tha

Updated on: December 19,2023

What Comes after NCI-MATCH? NCI’s New Precision Medicine Cancer Trials

SubscribeDecember 6, 2023, by James H. Doroshow, M.D.Findings from NCI-MATCH and its successor trials will help oncologists implement precision medicine in everyday patient care.Credit: iStockMore tha

Updated on:December 19,2023

WHO moves step closer to cheaper breast cancer treatment

The World Health Organization has approved a biosimilar version of Trastuzumab—the drug used to treat breast cancer—that is generally 65 percent cheaper than the originalThe World Health Organization

Updated on: December 22,2023

WHO moves step closer to cheaper breast cancer treatment

The World Health Organization has approved a biosimilar version of Trastuzumab—the drug used to treat breast cancer—that is generally 65 percent cheaper than the originalThe World Health Organization

Updated on:December 22,2023

What Is B-Cell Lymphoma?

What Is B-Cell Lymphoma?ByCorey WhelanPublished on February 23, 2022Medically reviewed byGagandeep Brar, MDB-cell lymphoma is a type ofnon-Hodgkin's lymphoma (NHL). N

Updated on: January 28,2024

What Is B-Cell Lymphoma?

What Is B-Cell Lymphoma?ByCorey WhelanPublished on February 23, 2022Medically reviewed byGagandeep Brar, MDB-cell lymphoma is a type ofnon-Hodgkin's lymphoma (NHL). N

Updated on:January 28,2024

New classification system for tumors can guide diagnosis and treatment options for cancer

by Center for Genomic RegulationCredit: CC0 Public DomainBased on the largest study of cancer patients of its kind, scientists have created a new way of classifying tumours. Clinicians can use genome

Updated on: December 22,2023

New classification system for tumors can guide diagnosis and treatment options for cancer

by Center for Genomic RegulationCredit: CC0 Public DomainBased on the largest study of cancer patients of its kind, scientists have created a new way of classifying tumours. Clinicians can use genome

Updated on:December 22,2023

Selpercatinib Significantly Improves PFS, Responses in Advanced RET+ Medullary Thyroid Cancer

October 21, 2023Gina MauroSelpercatinib resulted in a statistically significant improvement in progression-free survival and overall response rate compared with cabozantinib or vandetanib in patients

Updated on: October 24,2023

Selpercatinib Significantly Improves PFS, Responses in Advanced RET+ Medullary Thyroid Cancer

October 21, 2023Gina MauroSelpercatinib resulted in a statistically significant improvement in progression-free survival and overall response rate compared with cabozantinib or vandetanib in patients

Updated on:October 24,2023

Putting liquid biopsies on solid ground: Cancer diagnosis from a milliliter of blood

byWeizmann Institute of ScienceSingle-molecule DNA sequencing technical setup. Schematic representation of key instrumentation used to perform single-molecule DNA sequencing. Straight and dashed

Updated on: December 19,2023

Putting liquid biopsies on solid ground: Cancer diagnosis from a milliliter of blood

byWeizmann Institute of ScienceSingle-molecule DNA sequencing technical setup. Schematic representation of key instrumentation used to perform single-molecule DNA sequencing. Straight and dashed

Updated on:December 19,2023

Novel Genes Linked to Increased Breast Cancer Risk Discovered

byColleen Fleisson August 20, 2023Recently discovered genes linked tobreast cancermay eventually be incorporated into screening tests to detect higher risk levels in women .Bre

Updated on: December 19,2023

Novel Genes Linked to Increased Breast Cancer Risk Discovered

byColleen Fleisson August 20, 2023Recently discovered genes linked tobreast cancermay eventually be incorporated into screening tests to detect higher risk levels in women .Bre

Updated on:December 19,2023

How a patient partnership is propelling cancer research

by Leah Eisenstadt,Broad Institute of MIT and HarvardCount Me In Director Nikhil Wagle and Strategic Advisor Corrie Painter. Credit: Broad Institute of MIT and HarvardIn the fall of 2018, cancer

Updated on: December 19,2023

How a patient partnership is propelling cancer research

by Leah Eisenstadt,Broad Institute of MIT and HarvardCount Me In Director Nikhil Wagle and Strategic Advisor Corrie Painter. Credit: Broad Institute of MIT and HarvardIn the fall of 2018, cancer

Updated on:December 19,2023

Predicting lymphoma patients' treatment outcomes

byCedars-Sinai Medical CenterDistinct spatially resolved TME features according to relapse status. (A) Proportion for the indicated immune cell population by IMC-based cluster assignment. (B) Th

Updated on: December 26,2023

Predicting lymphoma patients' treatment outcomes

byCedars-Sinai Medical CenterDistinct spatially resolved TME features according to relapse status. (A) Proportion for the indicated immune cell population by IMC-based cluster assignment. (B) Th

Updated on:December 26,2023

Engineering the immune system to tackle glioblastoma

by Sally Sapega,University of PennsylvaniaCredit: University of PennsylvaniaEach year, roughly 15,000 Americans are diagnosed with Glioblastoma Multiforme (GBM), the most common malignant primar

Updated on: December 22,2023

Engineering the immune system to tackle glioblastoma

by Sally Sapega,University of PennsylvaniaCredit: University of PennsylvaniaEach year, roughly 15,000 Americans are diagnosed with Glioblastoma Multiforme (GBM), the most common malignant primar

Updated on:December 22,2023

Acute myeloid leukemia: Germany-wide clinical trial challenges international standard of care

by Nina Louis, Medizin & WissenschaftCredit:Blood(2022). DOI: 10.1182/blood-2022-159962Prior to allogeneic stem cell transplantation for the treatment of acute myeloid leukemia (AML),

Updated on: December 25,2023

Acute myeloid leukemia: Germany-wide clinical trial challenges international standard of care

by Nina Louis, Medizin & WissenschaftCredit:Blood(2022). DOI: 10.1182/blood-2022-159962Prior to allogeneic stem cell transplantation for the treatment of acute myeloid leukemia (AML),

Updated on:December 25,2023

Sub-lobar surgery for peripheral non-small cell lung cancer non-inferior to lobectomy

by International Association for the Study of Lung CancerCancer cell during cell division. Credit: National Institutes of HealthA large international study of patients with non-small cell lung cancer

Updated on: December 18,2023

Sub-lobar surgery for peripheral non-small cell lung cancer non-inferior to lobectomy

by International Association for the Study of Lung CancerCancer cell during cell division. Credit: National Institutes of HealthA large international study of patients with non-small cell lung cancer

Updated on:December 18,2023